Affiliated Managers Group Inc. 5.250% Senior Notes Due 2022 (AFM)

AFM Chart

Catalysts

News and Press Releases

We searched over 50 sources and couldn't find any news or press releases related to Affiliated Managers Group Inc. 5.250% Senior Notes Due 2022.

Here are some articles we think you might like.

• Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors

  GlobeNewsWire | July 1st

  ADGI
• Endeavor to buy sports betting business OpenBet for $800 million

  Reuters | June 30th

  EDR
• SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Talkspace, Inc.

  Newsfile Corp | June 30th

  TALK
• SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Telos Corporation

  Newsfile Corp | June 30th

  TLS
• Endeavor Slashes Price Of Its Pending Acquisition Of OpenBet By $400 Million As Market Flails

  Deadline | June 30th

  EDR
• ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT

  PRNewsWire | June 30th

  ISLE
• Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management

  GlobeNewsWire | June 30th

  RPID
• InnovAge Appoints James Carlson to the Board as Non-Executive Chairman

  GlobeNewsWire | June 30th

  INNV
• U.S. Public Sector, Facing Major Changes, Shifts to the Cloud

  Business Wire | June 30th

  III
• 3 Reasons Why Snowflake (NYSE: SNOW) Should Be In Your Portfolio

  MarketBeat | June 30th

  SNOW
• NextPlay Forming Strategic Partnership with iTAP to Position HotPlay Hyper-Casual Games and In-Game Advertising Technology into the Fast-Growing Indian Market

  GlobeNewsWire | June 30th

  NXTP
• Is Clover Health A Good Healthcare Sector Stock Pick?

  Seeking Alpha | June 30th

  CLOV
• Kennedy Lewis Investment Management LLC Announces Offer to Acquire Rapid Micro Biosystems

  PRNewsWire | June 30th

  RPID
• Entertainment And Retail Destination Distrito T-Mobile Keeps Visitors Safe With Evolv Technology

  Business Wire | June 30th

  EVLV
• Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

  Business Wire | June 30th

  AURA

Company Info